
TSE:HHL
This summary was created by AI, based on 6 opinions in the last 12 months.
The Healthcare Leaders Income ETF (HHL-T) holds a diversified portfolio of approximately 20-23 major healthcare companies, with a significant allocation in pharmaceuticals, healthcare equipment, and biotech. Experts recognize the recent pressures on the U.S. healthcare sector, primarily driven by economic factors and concerns around drug pricing, particularly amid political changes. Despite the negativity surrounding the sector, some analysts suggest that the current entry point may be favorable, as they anticipate a market normalization in response to demographic trends. The ETF employs a covered call strategy, offering a compelling dividend yield of 9-10%, but opinions are mixed on whether this strategy outperforms direct ownership of the underlying stocks. Overall, there's a cautious optimism regarding the ETF's potential for income generation and diversification within a broader portfolio.
LIFE vs. HHL In Canada, we have two similar ETFs holding global healthcare, this and HHL-T. Each holds around 20 megacap stocks, equally weighted. He prefers LIFE because the names it holds are more diverse, but owning either or both is fine. Both feature a covered call a third of their portfolios, which is good, because you want two-thirds to really capture the upside potential in this thriving sector. Who knows which set of stocks within these ETFs will hit? You could own both. Plus, you get a little income.
Made up of the 20 leading pharma companies. He likes this strategy. It's similar to LIFE-T though there are some differences. The healthcare space is in good shape for growth for years to come. A good growth enhancement name.
He likes the strategy. Healthcare with options strategies to enhance yield. LIFE-T is also an interesting way to play healthcare. Healthcare should be a growth area over the next few years although a change in government in the US could represent some risk.
He does not own this one. They have an effective covered call strategy and he has no issues with the fund at all. He prefers ZUH, where it is not impeded with calls being written.